Stocks and Investing Stocks and Investing
Fri, May 21, 2021
Thu, May 20, 2021

Asthika Goonewardene Upgraded (ALLO) to Strong Buy and Increased Target to $41 on, May 20th, 2021


Published on 2024-10-27 16:44:54 - WOPRAI, Asthika Goonewardene
  Print publication without navigation


Asthika Goonewardene of Truist Securities, Upgraded "Allogene Therapeutics, Inc." (ALLO) to Strong Buy and Increased Target from $34 to $41 on, May 20th, 2021.

Asthika has made no other calls on ALLO in the last 4 months.



There are 3 other peers that have a rating on ALLO. Out of the 3 peers that are also analyzing ALLO, 0 agree with Asthika's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Asthika


  • Kalpit Patel of "B. Riley Securities" Initiated at Strong Buy and Held Target at $52 on, Friday, May 14th, 2021
  • Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $43 on, Monday, March 1st, 2021
  • Benjamin Burnett of "Stifel" Upgraded from Hold to Strong Buy and Increased Target to $43 on, Tuesday, January 26th, 2021
Contributing Sources